Comparative Effects of Ramipril on Ambulatory and Office Blood Pressures
Top Cited Papers
- 1 December 2001
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Hypertension
- Vol. 38 (6), E28-32
- https://doi.org/10.1161/hy1101.099502
Abstract
In the HOPE-trial, the ACE inhibitor ramipril significantly reduced cardiovascular morbidity and mortality in patients at high risk for cardiovascular events. The benefit could only partly be attri...Keywords
This publication has 12 references indexed in Scilit:
- Ambulatory blood pressure monitoring: which arm?Journal of Human Hypertension, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Hypotension in patients with coronary disease: can profound hypotensive events cause myocardial ischaemic events?Heart, 1999
- Predicting Cardiovascular Risk Using Conventional vs Ambulatory Blood Pressure in Older Patients With Systolic HypertensionJAMA, 1999
- Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension.Hypertension, 1994
- Circadian Variation and Cardiovascular DiseaseNew England Journal of Medicine, 1991
- 24‐hour blood pressure profiles in hypertensive patients administered ramipril or placebo once daily: Magnitude and duration of antihypertensive effectsClinical Cardiology, 1991
- Blood pressure, stroke, and coronary heart diseaseThe Lancet, 1990
- HOW FAR SHOULD INDICATIONS FOR GROWTH HORMONE TREATMENT EXPAND?The Lancet, 1990
- First dose response and 24-hour antihypertensive efficacy of the new once-daily angiotensin converting enzyme inhibitor, ramiprilThe American Journal of Cardiology, 1988